Core Viewpoint - A securities fraud class action lawsuit has been filed against C3.ai, Inc. for alleged misrepresentations regarding the company's business and the impact of the CEO's health on its operations [3][4]. Group 1: Lawsuit Details - The lawsuit was initiated in the United States District Court for the Northern District of California on behalf of investors who acquired C3 securities between February 26, 2025, and August 8, 2025 [3]. - Allegations include that the CEO's health significantly affected C3 AI's ability to close deals and that management failed to mitigate this impact, hindering the company's profit and growth potential [4]. Group 2: Legal Participation - Investors wishing to serve as lead plaintiffs must file necessary documents by October 21, 2025, although participation as a lead plaintiff is not required to share in any potential recovery [5]. - All legal representation is on a contingency fee basis, meaning shareholders incur no fees or expenses [5]. Group 3: Law Firm Background - Bernstein Liebhard LLP, the law firm handling the case, has recovered over $3.5 billion for clients since 1993 and has represented large public and private pension funds [6]. - The firm has been recognized multiple times for its success in litigating class actions, being named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for sixteen consecutive years [6].
C3.AI, INC. (NYSE: AI) SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds C3.ai, Inc. Investors of Upcoming Deadline